March 2015 – Page 3 – Policy & Medicine

NLARx Dissolves–The National Legislative Association on Prescription Drug Prices Formed in 2000 Called It Quits Last Month

CMS Releases New Open Payments FAQs For Data Submission: Highlight New Matching Process, Renewing Delay In Publication

CMS Open Payments Q&A: Tuesday March 10, 1:30pm EST

Seventh Circuit Lands On Expansive Definition of “Referral” in Anti-Kickback Case

FDA Approves Sandoz’s Zarxio, The First Biosimilar Approved in the U.S.

Does Experience Matter? Study Finds Same Mortality Rates For Experienced and New Surgeons

DOJ Targets Small Pharma: Expects Companies To Mine Their Data For Misconduct; Finds Speaker Programs, Specialty Pharmacies, R&D “Prone to Abuse”

SEC Provides Insight Into The Foreign Corrupt Practices Act and Life Science Companies

French Sunshine Act Updated With More Stringent Reporting Requirements

Vermont Enforces Disclosure Law For Second Time This Year: $45,000 Penalty Against Dental Company For Failing to File Disclosure Reports